Ischemia Modified Albumin Protein (IMA)
IMA
Origin: Human
Host: Human
Native
> 90 %
SDS, WB, Imm, PC
-
- Target See all Ischemia Modified Albumin (IMA) products
- Ischemia Modified Albumin (IMA)
- Protein Type
- Native
- Origin
- Human
-
Source
- Human
- Application
- SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
- Purity
- > 90 %
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Isoelectric Point:
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute in sterile PBS, pH 7.2 - pH 7.4.
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Preservative
- ProClin
- Handling Advice
- Avoid repeated freeze/thaw cycles
- Storage
- 4 °C,-80 °C
- Storage Comment
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- Ischemia Modified Albumin (IMA)
- Alternative Name
- Ischemia Modified Albumin (IMA Products)
- Background
- Ischemia Modified Albumin is also called Human serum albumin. Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. It is soluble and monomeric. Albumin is synthesized in the liver as preproalbumin, which has an N-terminal peptide that is removed before the nascent protein is released from the rough endoplasmic reticulum. It has a molecular mass of 67 kDa. Human albumin is often used to replace lost fluid and help restore blood volume in trauma, burns and surgery patients. A Cochrane systematic review[6] of 37 trials found no evidence that albumin, compared with cheaper alternatives such as saline, reduces the risk of dying.
- Molecular Weight
- 68 kDa
-
You are here:
